CIK 0001735438 · Non-accelerated filer<br>Smaller reporting company
MeiraGTx Holdings plc
Sign in to watch- Ticker
- MGTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981448305
- Phone
- 646-860-7985
- Business address
- 655 THIRD AVENUE, SUITE 1115, NEW YORK, NY, 10017
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,710,812
- in 3 filings, $1.7M under 10b5-1 plans
Net −$1,710,812. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 30 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-07 | Zeldin Robert K CHIEF MEDICAL OFFICER | Option exercise | +35,000 | 85,487 | ||
| 2024-01-07 | Zeldin Robert K CHIEF MEDICAL OFFICER | Shares withheld for taxes | −18,507 | $6.30 | $117K | 66,980 |
| 2024-01-07 | Zeldin Robert K CHIEF MEDICAL OFFICER | Option exercise · Restricted Share Units | −35,000 | 35,000 | ||
| 2024-01-07 | Wollin Robert J GENERAL COUNSEL AND SECRETARY | Option exercise | +15,000 | 20,712 | ||
| 2024-01-07 | Wollin Robert J GENERAL COUNSEL AND SECRETARY | Shares withheld for taxes | −7,931 | $6.30 | $50K | 12,781 |
| 2024-01-07 | Wollin Robert J GENERAL COUNSEL AND SECRETARY | Option exercise · Restricted Share Units | −15,000 | 15,000 | ||
| 2024-01-07 | Naylor Stuart CHIEF DEV. OFFICER | Option exercise | +75,000 | 565,792 | ||
| 2024-01-07 | Naylor Stuart CHIEF DEV. OFFICER | Shares withheld for taxes | −35,250 | $6.30 | $222K | 530,542 |
| 2024-01-07 | Naylor Stuart CHIEF DEV. OFFICER | Option exercise · Restricted Share Units | −75,000 | 75,000 | ||
| 2024-01-07 | Giroux Richard CFO & COO | Option exercise | +105,000 | 879,994 | ||
| 2024-01-07 | Giroux Richard CFO & COO | Shares withheld for taxes | −55,520 | $6.30 | $350K | 824,474 |
| 2024-01-07 | Giroux Richard CFO & COO | Option exercise · Restricted Share Units | −105,000 | 105,000 | ||
| 2024-01-07 | Forbes Alexandria PRESIDENT & CEO | Option exercise | +125,000 | 1,404,489 | ||
| 2024-01-07 | Forbes Alexandria PRESIDENT & CEO | Shares withheld for taxes | −66,095 | $6.30 | $416K | 1,338,394 |
| 2024-01-07 | Forbes Alexandria PRESIDENT & CEO | Option exercise · Restricted Share Units | −125,000 | 125,000 | ||
| 2023-09-15 | Johnson & Johnson Innovation - JJDC, Inc. 10% owner | Other disposition | −6,641,064 | 0 | ||
| 2023-06-08 | Yu Debra Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2023-06-08 | Yu Debra Director | Grant or award · Restricted Share Units | +20,000 | 20,000 | ||
| 2023-06-08 | PERCEPTIVE ADVISORS LLC Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2023-06-08 | PERCEPTIVE ADVISORS LLC Director | Grant or award · Restricted Share Units | +20,000 | 20,000 |
Page 11 of 21 · 411 trades